Purdue Opioid Addiction

Tablet Medicine

Overview

Purdue Pharma is widely recognized as the primary catalyst and leading corporate driver of the American opioid crisis. While other pharmaceutical manufacturers and distributors eventually followed its playbook, Purdue’s entry into the market fundamentally altered medical perception and prescribing habits regarding opioids.

Purdue completely shifted how pain was treated in the United States by launching OxyContin in 1996. Historically, physicians were highly reluctant to prescribe strong opioids for anything other than short-term acute trauma or end-of-life cancer care due to the known risks of dependency. Purdue aggressively campaigned to expand the patient pool, convincing doctors to prescribe OxyContin for everyday, long-term chronic pain like arthritis, backaches, and sports injuries.

The finalized Purdue Pharma opioid settlement is a historic, multi-billion-dollar restructuring agreement designed to resolve thousands of lawsuits against the company and its owners, the Sackler family, for their role in fueling the opioid epidemic.

Following a major renegotiation necessitated by the Supreme Court’s 2024 ruling, the bankruptcy court approved an updated plan that officially became legally effective in spring 2026.

Enter Your Private Client Portal Page

Frequently Asked Questions

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

1. What is the Purdue Opioid Addiction litigation about?
The Purdue Pharma opioid litigation centers on allegations that the company, driven by its owners, the billionaire Sackler family, fueled the American opioid epidemic through the aggressively deceptive marketing of its blockbuster painkiller, OxyContin. Lawsuits filed by thousands of state, local, and tribal governments—as well as individual victims—argued that Purdue falsely minimized the drug’s severe addiction risks and pushed over-prescription for financial gain. The multi-year legal battle ultimately led to Purdue’s bankruptcy, a landmark 2024 Supreme Court ruling striking down nonconsensual legal immunity for the Sacklers, and a restructured multibillion-dollar settlement aimed at dissolving the company and directing its assets toward nationwide opioid treatment and victim compensation.
2. Am I eligible to be part of this lawsuit?
Anyone who was prescribed an opioid manufactured by Purdue, such as OxyContin by a medical professional and can show damages that resulted from an addiction to the medication is eligible to file a claim seeking compensation
3. What are we claiming against the defendants?
We are claiming that Purdue was aware of the risks of the opioid medication they were manufacturing, but they downplayed these risks when they aggressively marketed the drug.
4. How can I stay updated on this case?
You can stay updated by filling out our case inquiry form to receive direct email alerts regarding major milestones, court filings, and settlement updates. We will also publish key case developments directly to this website news feed.
5. How long will it take to get compensation
Every case is different and the plaintiffs are going to do everything they can to fight these claims. That said, it is not uncommon for litigation to take multiple years to reach a conclusion. We will contact you as necessary when we need documents from you. But, during the early stages of the litigation, we will focus on building the legal arguments and expert testimonies. So, it may be a while before we need your input. Please be patient while we work through these first stages.

Do You Have A Question?


Video Archives

Documents

Purdue Pharma’s opioid drug information

Brent Coon & Associates is representing people who became addicted to Purdue Pharma’s opioid drugs OxyContin, MS OxyContin, Contin, and Ryzolt.  The deadline to file claims has now passed.  The Bankruptcy Court is expected to have a confirmation hearing regarding...

News Archives

​Purdue Opioid Addiction – Q1 2022 Update

As expected, the bankruptcy plan was confirmed by the Bankruptcy Court last fall.  Part of that plan involved the Sackler family, who owned Purdue Pharma, contributing several hundred million dollars to the bankruptcy trust in exchange for protections for future legal...